Pursuant to Regulation 33 and Regulation 30 read with Part A of Schedule III of SEBI (LODR)Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meetingheld today i.e. 14th November, 2024 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2024. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2024.
Board Meeting Outcome for Board Meeting Held On 14Th November 2024
Filed with BSE · · 6 pages · English
Release
Rekvina Laboratories Ltd. on 6ix
Earlier from Rekvina Laboratories
- Rekvina Laboratories Ltd. Press Release Nov 08 2024
- Board Meeting Intimation for Board Meeting To Be Held On 14Th November, 2024.
Later from Rekvina Laboratories
- Financial Result For Quarter And Half Year Ended On 30Th September 2024.
- Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) (Amendment) Regulations, 2018, For The Half Year Ended On 30.09.2024.
- Rekvina Laboratories Ltd. Press Release Nov 14 2024
- Appointment of Company Secretary and Compliance Officer
- Rekvina Laboratories Ltd. Press Release Dec 04 2024
Follow Rekvina Laboratories into a list and get an email when it puts out news.
Follow Rekvina Laboratories